• Careers
  • Contact
  • In the News
Crescendo
  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Investors
  • Humabody®
    • Overview
    • Transgenic VH Platform
    • Humabody® Therapeutics
  • Pipeline
    • Overview
    • Our Proprietary Pipeline
    • Our Assets for Partnering
    • Collaboration Programmes
  • Partnering
  • Media
    • Press Releases
    • Events
    • Press Kit
    • Videos
  • Menu

Of Mice and Men: Building Multifunctional Biologics to Treat Disease

25 October 2017/in homepage, In the News /by fr00fRoU

Of Mice and Men: Building Multifunctional Biologics to Treat Disease

MedNous

/wp-content/uploads/2016/02/logo_crescendo.png 0 0 fr00fRoU /wp-content/uploads/2016/02/logo_crescendo.png fr00fRoU2017-10-25 13:39:392017-11-06 16:45:43Of Mice and Men: Building Multifunctional Biologics to Treat Disease

Recent Posts

  • Crescendo Biologics Appoints Eva-Lotta Allan as Non-Executive Director
  • Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications
  • Crescendo Biologics Ltd. Raises $70 Million (€57 Million) in Series B Financing
  • Crescendo Biologics Reaches First Major Milestone in Strategic Collaboration with Takeda
  • CEO Peter Pack interviewed by Scrip at Bio-Europe Spring 2018

Archives

  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • February 2017
  • January 2017
  • November 2016
  • October 2016
  • September 2016
  • April 2016
  • February 2016
  • November 2015
  • October 2015
  • May 2015
  • March 2015
  • January 2015
  • December 2014
  • October 2014
  • April 2014
  • March 2014
  • December 2013
  • January 2013
  • October 2012
  • August 2012
  • June 2011
  • April 2011
  • January 2011
  • September 2010
  • January 2010
  • October 2009

Humabody® is a registered trademark of Crescendo Biologics Ltd.

Meditrina Building 260, Babraham Research Campus, Cambridge, CB22 3AT
© 2016 Crescendo Biologics  ·  privacy policy  · website by Instinctif Partners
Developing differentiated, multifunctional immuno-oncology products Antibody Engineering & Therapeutics Conference
Scroll to top